Home Archives 2011 December

Monthly Archives: December 2011

The January 2012 issue of the Journal of Commercial Biotechnology is now available. Contents include Original Articles, From the Boardroom, From the Classroom, Legal and Regulatory Update, and Book Reviews.

Individual papers are available for purchase. Subscription options are posted at http://commercialbiotechnology.com/about/subscriptions , and you may also request that your librarian subscribe at http://commercialbiotechnology.com/pages/view/library-subscription .

Table of Contents

Editorial

Exciting changes
Yali Friedman

Articles

Bacterial proteins: A new class of cancer therapeutics
Ananda Mohan Chakrabarty
Industrial biotechnology – Markets and industry structure
Gunter Festel, Christian Detzel, Ruth Maas
Options to Change Medicare Payment for Outpatient Prescription Drugs and Biotechnology Products
Thomas Barker, Maia Larsson
The Emergence of Bio-Clusters in Egypt and South Africa
Ramazan Uctu, Nirvana Shanalee Pillay
Patent litigation in India and interim injunctions — An evolving jurisprudence
Rajashree Sharma, Dinesh Kumar Sharma

From the Boardroom

Digital health investment opportunities abound, but standouts deliver disruptive change
G. Steven Burrill
Strategies for Collaboration Agreements Focusing on Innovation
Pamela Cox
Biomarketing strategy and tactics 101 PART I of III
Dimitris Dogramatzis

From the Classroom

The University of Colorado Certificate Program in Bioinnovation and Entrepreneurship: An Interdisciplinary, Cross-Campus Model
Madhavan Parthasarathy, David Forlani, Arlen Meyers

Legal and Regulatory Updates

EU Legal & Regulatory Update
Ewan Grist
Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies
Smitha Uthaman, Deborah Lu, Thomas Kowalski

Book Reviews

Book Review: Constructing and Deconstructing Patents by Irah H. Donner
David B. Orange
Book Review: Plunkett’s Biotech & Genetics Industry Almanac 2012
Barry J. Marenberg

For more information, see the Journal of Commercial Biotechnology at http://CommercialBiotechnology.com

The January 2012 issue of the Journal of Commercial Biotechnology is ready to go to press. The table of contents is posted below. Like what you see? Subscribe or recommend the journal to your library.

Journal of Commercial Biotechnology Vol 18, Issue 1 (2012) (Preview)

Table of Contents

Editorial

Exciting changes
Yali Friedman

 

Articles

Bacterial proteins: A new class of cancer therapeutics
Ananda Mohan Chakrabarty
Industrial biotechnology – Markets and industry structure
Gunter Festel, Christian Detzel, Ruth Maas
Options to Change Medicare Payment for Outpatient Prescription Drugs and Biotechnology Products
Thomas Barker, Maia Larsson
The Emergence of Bio-Clusters in Egypt and South Africa
Ramazan Uctu, Nirvana Shanalee Pillay
Patent litigation in India and interim injunctions — An evolving jurisprudence
Rajashree Sharma, Dinesh Kumar Sharma

 

From the Boardroom

Digital health investment opportunities abound, but standouts deliver disruptive change
G. Steven Burrill
Strategies for Collaboration Agreements Focusing on Innovation
Pamela Cox
Biomarketing strategy and tactics 101 PART I of III
Dimitris Dogramatzis

 

From the Classroom

The University of Colorado Certificate Program in Bioinnovation and Entrepreneurship: An Interdisciplinary, Cross-Campus ModelPDF Restricted Access
Madhavan Parthasarathy, David Forlani, Arlen Meyers

 

Legal and Regulatory Updates

EU Legal & Regulatory Update
Ewan Grist
Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies
Smitha Uthaman, Deborah Lu, Thomas Kowalski

 

Book Reviews

Book Review: Constructing and Deconstructing Patents by Irah H. Donner
David B. Orange
Book Review: Plunkett’s Biotech & Genetics Industry Almanac 2012
Barry J. Marenberg

 

Do you enjoy the Journal of Commercial Biotechnology sample papers and want complete access to journal?

Librarians appreciate input from their constituents — you can use the library suggestion form on the JCB website to let your librarian know that you would like them to subscribe.

As a bonus, if your library purchases an institutional subscription following your referral, they will also get a free book from Logos Press.

Drug Patent Expirations in December 2011

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
OMNICEFAbbottcefdinir4,935,507Dec 4, 2011
AMPYRAAcordadalfampridine5,370,879Dec 6, 2011
AVELOXBayer Hlthcaremoxifloxacin hydrochloride4,990,517Dec 8, 2011
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINERBayer Hlthcaremoxifloxacin hydrochloride4,990,517Dec 8, 2011
ACCOLATEAstrazenecazafirlukast6,143,775Dec 11, 2011
ACCOLATEAstrazenecazafirlukast5,319,097Dec 11, 2011
ACCOLATEAstrazenecazafirlukast5,294,636Dec 11, 2011
MOTRINMcneil Pedibuprofen5,320,855*PEDDec 14, 2011
TROVANPfizertrovafloxacin mesylate5,164,402Dec 18, 2011
PALLADONEPurdue Pharma Lphydromorphone hydrochloride5,968,551Dec 24, 2011
PALLADONEPurdue Pharma Lphydromorphone hydrochloride6,294,195Dec 24, 2011
MYCAMINEAstellasmicafungin sodium5,376,634Dec 27, 2011
PRIALTAzur Pharma Iiziconotide5,859,186Dec 30, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com